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eft Atrial Roof Ablation
s More Important Than
ulmonary Vein Isolation in
erminating Persistent Atrial
ibrillation in a Canine Model
hould We Perform a Left Atrial Roof
ine in All Atrial Fibrillation Ablations?*
. Paul Mounsey, BM, BCH, PHD
hapel Hill, North Carolina
eft atrial (LA) ablation for persistent atrial fibrillation
AF) as performed in most electrophysiology laboratories in
010 has developed from an amalgamation of several
ifferent approaches. The idea that rapidly discharging atrial
achycardia foci usually located in the pulmonary veins could
erve as a driver for high-density paroxysmal AF in patients
ith minimal structural heart disease (1) led to attempts to
reat more complex AF with pulmonary vein isolation (PVI)
rocedures that were ultimately disappointing (2). Addition
f linear ablation lesions principally in the atrial roof
between the left and right superior pulmonary veins) and
itral isthmus (between the left inferior pulmonary vein and
he mitral annulus) led to improved success rates, especially
n patients with paroxysmal AF and coexistent LA enlarge-
ent (3) and in patients with persistent AF (4). Ablation of
omplex fractionated atrial electrograms (CFAEs) (5) with
r without concomitant autonomic denervation from gan-
lionated plexus ablation (6) has been used as a stand-alone
pproach to AF ablation with success in some (5) but not all
7) reports.
See page 1728
With these considerations in mind, most would use a
tepwise approach to catheter ablation of persistent AF (8).
his begins with isolation of the pulmonary veins, usually as
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Cardiac Electrophysiology Laboratory, University of North Carolina,s
hapel Hill, North Carolina. Dr. Mounsey acts as a consultant to Medtronic Inc., St.
ude Medical Inc., and Boston Scientific Corporation.wide-area circumferential ablation. Ablation of CFAEs,
n LA roof line, and a mitral isthmus line and isolation of
he coronary sinus are other components of the lesion set;
ome would also search for CFAEs in the right atrium (5).
he order and extent in which the extra–pulmonary vein
esion set is applied is variable. For example, if the AF
rganizes to an atrial tachycardia, this will be ablated next
nd the procedure ended if sinus rhythm is obtained.
Which elements of the lesion set are most important for
rrhythmia cure? Addition of CFAE ablation to wide-area
ircumferential pulmonary vein ablation did not enhance
utcomes in patients with persistent AF, but other potential
esion sets were not made (9). In patients with paroxysmal
F, randomization between an LA roof line or a mitral
sthmus line for persistently inducible AF after PVI resulted
n comparable success rates, and many patients required
oth lesions to render them noninducible (10). A compar-
son of pulmonary vein encirclement and linear LA lesions,
ith empiric LA linear lesions made through areas with
FAEs but deliberately not encircling the pulmonary veins,
esulted in a similar success rate in patients with persistent
F (11). It is not clear, however, from this report which
inear lesions were the most important in interrupting AF.
Linear lesions can terminate AF in canine models with-
ut PVI. In a model of vagally induced AF, a biatrial lesion
et rendered AF noninducible (12). In atrial tachypacing
odels, AF was sometimes abolished by right atrial ablation
lone, although additional LA lesions were often required
13). The pulmonary veins seem to be less important in
ustaining canine AF in that AF remained inducible after
esection of the pulmonary veins (14,15). Canine AF thus
esponds to ablation differently from human AF.
It is in these contexts that the report by Nishida et al. (16)
n this issue of the Journal needs to be viewed. These
nvestigators assessed the effects of PVI or an LA roof line,
r both, in an atrial tachypacing model of canine AF. This
s a “pure” model of persistent AF, a situation in which
riggering from the pulmonary veins is likely to be of little
ignificance in perpetuating the arrhythmia. Their major
nding was that LA roof ablation alone was able to
erminate AF in many cases, whereas PVI did so rarely. LA
oof ablation also suppressed AF perpetuation but did not
ffect vulnerability. In contrast, PVI did suppress the initi-
tion of AF but did not affect the perpetuating substrate.
The major electrophysiological effect of PVI was a reduc-
ion of the atrial effective refractory period (ERP). This
ffect translated into an effect on AF vulnerability in that
acing sites with AF induction had shorter ERPs overall,
nd where ERP was prolonged after PVI, previous AF
nduction was suppressed. The mechanism for prolongation
f the atrial ERP after PVI is not clear but may be related
o the ablation of autonomic ganglia close to the pulmonary
ein ostia. If this is the case, it would be anticipated that the
ffect would be ameliorated over time, because it has been
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Left Atrial Roof Ablation November 16, 2010:1737–9esion set heals (6,17). It would be of interest to repeat the
xperiments in a set of dogs that were allowed to recover
fter ablation to further investigate this possibility.
The absence of an effect of PVI on the duration of AF
pisodes in this model must be interpreted in the context
f the almost purely re-entrant model of AF under study.
uman AF is likely to be a much less pure condition in
hich high-frequency driver activity coming from the
ulmonary veins would interact with intra-atrial re-entry
o maintain persistence of the arrhythmia. Ablation of
uch pulmonary vein drivers, although usually ineffective
hen performed as the sole lesion set in persistent AF in
atients, may have more of a role than seen in this
e-entrant model.
In contrast to PVI, LA roof ablation had no effect on
trial refractoriness or vulnerability but did reduce the
uration of AF episodes. The major mechanism of this
ppeared to be a reduction in the dominant frequency of
he AF episodes. Activation mapping revealed re-entrant
ave fronts that frequently reactivated adjacent tissue in
he LA roof. Ablation of the roof resulted in lower
requency activation (explaining the reduction in domi-
ant frequency) with much less complexity of activation
n the left atrium. In fact, AF was frequently maintained
y re-entry in the right atrium and often terminated
pontaneously.
After completion of either lesion set, macro–re-entrant
achycardias similar to those seen in patients were com-
only induced. After PVI, these were most commonly seen
ircling round the ablation lesion. After roof ablation,
utters were most commonly perimitral. LA tachycardias
re commonly seen after LA ablation in patients, and both
ocal and re-entrant mechanisms are observed (8). Re-
ntrant tachycardias are commonly but not exclusively
elated to gaps in the ablation lines, and both perimitral
ircuits and flutters encircling pulmonary veins are reported.
hether an isolated roof line, as performed here, might
ead to a macro–re-entrant perimitral atrial flutter in a
atient is not known.
Should the data reported by Nishida et al. (16) affect the
ay we approach catheter ablation in patients with persis-
ent AF? Given that the data were collected in a canine
odel of re-entrant AF, and in the absence of the complex-
ty of structural heart disease encountered in patients with
ersistent AF, any translation to patients must be under-
aken with extreme caution. The data certainly provide a
ationale for the known benefit of linear roof ablation when
erformed alongside PVI, but the idea that limiting an
blation procedure to a single linear lesion in a patient with
ersistent AF would require testing in a prospective trial
efore it could be recommended for routine use. On the
asis of the data reported here, it is possible that a single
tep in the stepwise ablation process commonly deployed
urrently might be the crucial one in determining the
utcome of the procedure. Enthusiasm for this possibilityust be tempered somewhat, however. Canine atria are
uch smaller than human atria, and it is possible that in the
linical situation, a critical mass of LA re-entry might still
e possible even after successful roof ablation. The present
ata may stimulate critical reevaluation of the stepwise
pproach to ablation of persistent AF, perhaps in a trial of
VI along with other elements of the lesion set in random-
zed order.
In conclusion, Nishida et al. (16) report in a canine model
f persistent AF that PVI and LA roof ablation have widely
ifferent effects on atrial electrophysiology and AF arrhyth-
ia substrate. PVI led to prolongation of atrial refractori-
ess associated with reduced atrial vulnerability but no effect
n the duration of AF episodes. LA roof ablation frequently
erminated episodes of AF and reduced the duration of
nduced AF episodes through a reduction in local atrial
eactivations caused by re-entrant waveforms. These chal-
enging and exciting data point toward a reassessment of the
tepwise deployment of LA lesion sets in persistent AF.
eprint requests and correspondence: Dr. J. Paul Mounsey,
niversity of North Carolina, CB 7075, 160 Dental Circle,
hapel Hill, North Carolina 27514. E-mail: pmounsey@
ed.unc.edu.
EFERENCES
1. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of
atrial fibrillation by ectopic beats originating in the pulmonary veins.
N Engl J Med 1998;339:659–66.
2. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for
paroxysmal and persistent atrial fibrillation. Circulation 2002;105:
1077–81.
3. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal
atrial fibrillation: segmental pulmonary vein ostial ablation versus left
atrial ablation. Circulation 2003;108:2355–60.
4. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-
vein ablation for chronic atrial fibrillation. N Engl J Med 2006;
354:934–41.
5. Nademanee K, McKenzie J, Kosar E, et al. A new approach for
catheter ablation of atrial fibrillation: mapping of the electrophysi-
ologic substrate. J Am Coll Cardiol 2004;43:2044–53.
6. Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denerva-
tion enhances long-term benefit after circumferential ablation for
paroxysmal atrial fibrillation. Circulation 2004;109:327–34.
7. Oral H, Chugh A, Good E, et al. Radiofrequency catheter ablation of
chronic atrial fibrillation guided by complex electrograms. Circulation
2007;115:2606–12.
8. Haïssaguerre M, Sanders P, Hocini M, et al. Catheter ablation of
long-lasting persistent atrial fibrillation: critical structures for termi-
nation. J Cardiovasc Electrophysiol 2005;16:1125–37.
9. Oral H, Chugh A, Yoshida K, et al. A randomized assessment of the
incremental role of ablation of complex fractionated atrial electrograms
after antral pulmonary vein isolation for long-lasting persistent atrial
fibrillation. J Am Coll Cardiol 2009;53:782–9.
0. Jaïs P, Hocini M, Sanders P, et al. Long-term evaluation of atrial
fibrillation ablation guided by noninducibility. Heart Rhythm 2006;3:
140–5.
1. Oral H, Chugh A, Good E, et al. Randomized comparison of
encircling and nonencircling left atrial ablation for chronic atrial






1739JACC Vol. 56, No. 21, 2010 Mounsey
November 16, 2010:1737–9 Left Atrial Roof Ablation2. Elvan A, Pride H, Eble J, Zipes D. Arrhythmias/radiofrequency
ablation: Radiofrequency catheter ablation of the atria reduces induc-
ibility and duration of atrial fibrillation in dogs. Circulation 1995;91:
2235–44.
3. Elvan A, Huang XD, Pressler ML, Zipes DP. Radiofrequency
catheter ablation of the atria elmiminates pacing induced sustained
atrial fibrillation and reduces connexin 43 in dogs. Circulation 1997:
96;1675–85.
4. Cha TC, Ehrlich JR, Zhang L, Chartier D, Leung TK, Nattel S.
Atrial tachycardia remodeling of pulmonary vein cardiomyocytes:
comparison with left atrium and potential relation to arrhyth-
mogenesis. Circulation 2005;111:728–35. K5. Lemola K, Chartier D, Yeh YH, et al. Pulmonary vein region ablation
in experimental vagal atrial fibrillation: role of pulmonary veins versus
autonomic ganglia. Circulation 2008;117:470–7.
6. Nishida K, Sarrazin J-F, Fujiki A, et al. Roles of the left atrial roof and
pulmonary veins in the anatomic substrate for persistent atrial fibril-
lation and ablation in a canine model. J Am Coll Cardiol 2010;
56:1728–36.
7. Oh S, Zhang O, Bibevski S, Marrouche NF, Natale A, Mazgalev TN.
Vagal denervation and atrial fibrillation inducibility: epicardial fat pad
ablation does not have long-term effects. Heart Rhythm 2006;3:701–8.ey Words: ablation y atrial fibrillation y electrophysiology y re-entry.
